Industry Briefs April 2014

Agnitio Unveils Rainmaker


Agnitio, a premier CLM software provider, unveiled Rainmaker as the next wave of clinical digital communications. According to the company, Rainmaker allows users to build a central repository of approved content that medical professionals can access when they need it and on the device of their choice to engage in more meaningful ways. The new software, the company adds, offers pharmaceutical sales and marketing teams benefits that include personalized communication services and healthcare professional support.

Novartis Provides Second University with MenB Vaccine

In response to an outbreak of the potentially deadly meningitis B disease, the FDA granted special use of Bexsero, Novartis’ meningococcal serogroup B (MenB) vaccine, which it made available for use to two universities. Five thousand Princeton University students have already received the vaccine, while another 20,000 students at the University of California Santa Barbara will also receive Bexsero.

Novartis is also seeking a U.S. license to allow an immediate public health response to outbreaks and make the vaccine available to U.S. families. While rare, MenB is a bacterial infection that progresses rapidly and can lead to death or permanent disability within 24 hours.

Capsule Launches First MDIS

Capsule Tech, the leading global provider of medical device integrations solutions, recently launched the SmartLinx Medical Device Information System (MDIS), the industry’s first MDIS. According to the company, powerful surveillance tools and actionable information allow the MDIS to enable clinicians to recognize the signs of a patient’s physiological deterioration and take immediate action before the onset of adverse events.

Upsher-Smith Launches Seizure Clusters Connect


A new educational program created for patients living with seizure clusters was recently launched by Upsher-Smith. The initiative, called Seizure Clusters Connect, uses traditional and social media to offer patients and their caregivers a community for learning and support, according to the company. Seizure Clusters community resources include a Facebook page and a YouTube Channel.

Resolution Media Launches Current@Resolution

Omnicom Media Group’s global search and social performance agency, Resolution Media, launched Current@Resolution, a platform that provides expertise in four service areas including insights, rapid content planning and creation, paid amplification and analytics to enable more responsive and measurable social content and advertising programs, according to the company. It is designed to deliver a comprehensive, turn-key solution that increases the effectiveness of a company’s social investment.

Cumberland Acquires Vaprisol from Astellas

Cumberland Pharmaceuticals recently acquired Vaprisol, a patented, prescription brand used to raise serum sodium levels in hospitalized patients with hyponatremia, from Astellas. Cumberland’s immediate plan is to ensure a smooth transition of product supply and medical support to current brand users. Under the terms of the agreement, Cumberland will assume full responsibility for the product including its marketing, distribution and manufacture. Hyponatremia is associated with many diseases including congestive heart failure, liver and kidney failure and pneumonia.

Endo Completes Acquisition of Paladin Labs

Endo International has completed the acquisition of Paladin Labs in a stock and cash transaction valued at $2.7 billion. According to the company, the acquisition accelerates Endo’s strategic transformation into a leading global specialty healthcare company and creates a platform for future growth in North America and around the globe.


You May Also Like

Inspire Brand Loyalty Through the 5 Senses

After you read this sentence, close your eyes briefly and think about the creative ...

The Power of Positive Thinking

The end of the year is a hopeful time for me. I approach every ...

Value-based Care Hits the Medical Device Industry

The impact of the Affordable Care Act (ACA) on healthcare spending is hotly debated ...